The shareholders of Neimeth international pharmaceuticals PLC at the company’s 60th annual general meeting applauded the board and management for its efforts made in returning the company to profitability.
The drug maker came out of the woods, reporting a Profit After Tax of N184 million in its
```
Members Only
Login or create an account to continue
This article is available to registered BusinessDay readers. Please login if you already have an account, or create a new account to continue reading.
New to BusinessDay? Register now and start reading.
```
